to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events
Multifunctionalization of magnetic nanoparticles for controlled drug release: a general approach
Pala, R., Orhan, C., Tuzcu, M., Sahin, N., Ali, S., Cinar, V., Atalay, M., & Sahin, K
Middle-range protocol design: The common daily range is often split morning and evening because that schedule better matches the way many researchers think about repeated peptide signaling
Significant Skin Laxity Candidates typically have sagging or redundant skin, not simply stubborn pockets of fat
Add each solvent one by one: PBS Solubility: 100 mg/mL (325.39 mM)